DAX+0,30 % EUR/USD-0,05 % Gold+0,33 % Öl (Brent)-0,04 %

RavenQuest Sofa - Neueste Beiträge zuerst (Seite 3)

Beitrag schreiben

Begriffe und/oder Benutzer


Mal eine kurze Frage an die hier besser informierten. Man wartet hier ja noch auf eine Lizenz. So wie viele andere Cannabisfirmen vermutlich. Beginnt die Lieferung an Wayland erst mit Erteilung der Lizenz. Oder können die Lieferungen bereits jetzt stattfinden bzw. finden sie schon statt.
Denn die fehlende Lizenz ist ein Grund, weshalb ich hier bislang nicht eingestiegen bin. Der andere Grund ist Bonify. Da ich mir noch keine endgültige Meinung gebildet habe, ob das Theater bei Bonify eher besser oder schlechter für Ravenquest ist.
Antwort auf Beitrag Nr.: 59.858.617 von Bernhardow am 13.02.19 02:43:36Bernhardow,

Keine Ahnung.
Steht doch drin.
Das ist Ein Bericht wie Das Kifferzeug in Kanada anläuft.

Soll man da noch mehr erzählen?
Lesenswert ;)
"United States

Key marijuana chemical called CBD can no longer be added to food, drinks in NYC


Incidents of marijuana poisoning more than triple in Quebec since legalization


World's biggest cannabis farm to be built two hours outside of Brisbane

World Cannabis News

8/02/2019 Chronic pain most common reason U.S. patients get medical marijuana - Almost two-thirds of patients in the U.S. who get medical marijuana are using it as a treatment for chronic pain, a new study suggests. That’s in line with the large number of Americans who suffer chronic pain and the strong scientific evidence that marijuana is an effective pain treatment, the authors report in Health Affairs. Thirty-three U.S. states and the District of Columbia have legalized cannabis for medical use since 1996, and 10 states have legalized it for recreational use since 2012, the study team notes. Patients receiving cannabis for medical purposes need a license issued in states where this is legal, and licenses require a doctor to certify that patients have a condition that qualifies for treatment with marijuana, reports Reuters;
8/02/2019 Cannabis craze weeds out junior mining field - A boom in cannabis investment is siphoning capital away from mining and hitting junior miners hardest, forcing them to up their game and potentially improving the quality of projects in a sector long rife with cowboy speculators. Canada’s relaxation of cannabis laws culminated in legalization for recreational use in October. Other jurisdictions are following suit or liberalizing their laws on medical or health use, creating an industry that has lured a breed of high-risk, high-return investors. The world’s top three listed cannabis companies - Canopy Growth, Tilray and Aurora Cannabis - have a combined market value of around $30 billion. And consumers are expected to spend over $7 billion on cannabis products in Canada alone this year, according to Deloitte. In Africa, where miners met this week for Cape Town’s African Mining Indaba conference, cannabis companies are setting up projects in Lesotho, while other countries, including Zimbabwe and South Africa, plan to issue license, reports Reuters;
8/02/2019 Incidents of marijuana poisoning more than triple in Quebec since legalization - Incidents of cannabis poisoning in the Canadian province of Quebec have more than tripled since marijuana was legalized for recreational use, according to the local poison center, who have filed a report with the public health department. The group has announced 89 recorded cases of marijuana poisoning between October and December of 2018, compared to 25 cases in the same time frame the previous year, according to CBC. The symptoms of marijuana poisoning are characterized by a similarity to alcohol poisoning: high heart rate and blood pressure, anxiety, vomiting, and occasionally psychosis severe enough to require hospitalization. However, unlike alcohol poisoning, it is not simply caused by consuming too much of the drug, reports Fox News;
7/02/2019 Legalization May Come Soon. Who Will Wear the Cannabis Crown? - The U.S. federal ban on cannabis may soon come to an end. But the fragmented market makes it difficult to pick a winner, Piper Jaffray says. “We believe successful brands can emerge in the US, likely built on product differentiation, but in early stages of a new industry, it can be hard to identify long-term winners ” analyst Michael Lavery wrote in a note to clients. Lavery predicts the legalization of cannabis and products with THC may come in the next two to five years. Even as some emerging U.S. brands such as MedMen Enterprises Inc., Lowell Herb Co., and Pax Labs Inc. appear to have early traction, the market is still highly fragmented. That leaves a big hole for Canadian operators like Canopy Growth Corp. and Tilray Inc. to enter if laws change. Not to say American cannabis companies aren’t trying. MedMen is looking to drive higher in-house brand sales to lift margins. Lowell is currently the leader of pre-rolled joints in California, with 35 percent market share. Pax only produces hardware, avoiding the risks associated with a plant-touching business, reports Bloomberg;
6/02/2019 World's biggest cannabis farm to be built two hours outside of Brisbane - The world's biggest cannabis farm is on track to be built on the outskirts of a regional city two hours outside of Brisbane. Canadian-based company Asterion Cannabis has announced, via its wholly-owned Australian subsidiary, plans to invest at least $10 million into their new project in rural Queensland. The company has set itself ambitious goals and hopes their latest venture will have an annual cannabis production capacity in excess of 500,000 kg. The company said their latest venture will aim to be the largest greenhouse cannabis production facility the world has ever seen. Asterion Cannabis plans to build the farm across approximately 75 hectares (185 acres) of land close to the city of Toowoomba in southern Queensland, with an option for Asterion to purchase up to an additional 15 hectares (37 acres), reports Daily Mail;
6/02/2019 Marijuana use may boost sperm count, study claims - A new study from Harvard University researchers found men who smoke marijuana have significantly higher sperm counts than non-tokers. The findings, published Wednesday in the journal Human Reproduction, fly in the face of previous studies that suggest smoking pot can adversely affect male fertility. The team at Harvard tested 662 men who were enrolled at the Massachusetts General Hospital Fertility Center between 2000 and 2017. From the pool, they collected 1,143 semen samples. The 365 men who reported having ever smoked pot had “significantly higher sperm concentration” — precisely 63 million sperm per milliliter of semen — compared to the 297 who have never taken a hit, which averaged 45 million/mL. There were no significant differences in sperm counts between current and former marijuana smokers, reports Fox News;
6/02/2019 The First Marijuana Hearing Of The New Congress Has Been Scheduled - Congressional Democrats are already moving ahead with plans to consider broad changes to federal marijuana laws in 2019. Whereas the Republican-controlled House for the past several years had blocked votes on most cannabis-related measures, the chamber's new Democratic majority on Wednesday announced it has scheduled a hearing for next week to examine the difficulties that marijuana businesses face in opening and maintaining bank accounts. Titled, “Challenges and Solutions: Access to Banking Services for Cannabis-Related Businesses” the hearing will take place on February 13 before a subcommittee of the House Financial Services Committee. Although a growing number of states are moving to legalize marijuana for medical or recreational use, cannabis remains federally prohibited, reports Forbes;
6/02/2019 Scientists Are Racing to Make Weed As Easy to Drink as Beer - People who drink alcohol typically learn the hard way how much is too much—usually in their teens or early 20s. As adults, they’re not interested in learning the same hard-knocks lesson about cannabis. This is the challenge for an industry seeking to win over new or inexperienced users as legalization spreads through North America and around the world. It’s a particularly daunting one for makers of cannabis-infused beverages, which are keen to participate in a category that researcher Canaccord Genuity Group Inc. expects will be worth $600 million in the U.S. by 2022. learning the same hard-knocks lesson about cannabis. This is the challenge for an industry seeking to win over new or inexperienced users as legalization spreads through North America and around the world. It’s a particularly daunting one for makers of cannabis-infused beverages, which are keen to participate in a category that researcher Canaccord Genuity Group Inc. expects will be worth $600 million in the U.S. by 2022. That market potential has attracted several big alcohol companies that are seeking to offset declining beer consumption with the next big thing. The best-known partnership is Constellation Brands Inc.’s 38 percent stake in Canopy Growth Corp., the largest cannabis firm by market value, for which it paid about $4 billion, reports Bloomberg;
6/02/2019 Canadian Pot ETF Retakes Billion-Dollar Mark on Stock Surge - The New Year’s rally in pot stocks has sent assets in the first marijuana exchange-traded fund back above C$1 billion for the first time since Oct. 18, the day after Canada legalized recreational pot. The Horizons Marijuana Life Sciences Index ETF reclaimed the C$1 billion ($761 million) mark on Monday. Assets in the fund had dipped as low as C$624 million on Dec. 21. The Horizons Marijuana ETF, better known by its ticker HMMJ, was the first exchange-traded fund to track the cannabis industry but it’s no longer the biggest. That honor belongs to the U.S.-based ETFMG Alternative Harvest ETF, which surpassed $1 billion in assets this week for the first time. Pot stocks have been climbing steadily since their Christmas Eve low, with HMMJ up 56 percent and the ETFMG fund up 58 percent since the close on Dec. 24. Both are still well below their highs, however. HMMJ was trading at C$21.63 at 11:30 a.m. in Toronto, 20 percent below below its Oct. 16 high of C$27, reports Bloomberg;
5/02/2019 NYC Cracks Down on Businesses Selling CBD-Infused Food and Drinks - New York City is cracking down on the sale of food and drinks containing cannabidiol, a derivative of the cannabis plant that has been marketed as having therapeutic benefits. Inspectors for the Department of Health and Mental Hygiene have started to embargo products that contain cannabidiol, or CBD, during regular, periodic restaurant inspections. Products containing CBD can’t be served, and health officials are advising restaurants to strike CBD items from menus. “The Health Department takes seriously its responsibility to protect New Yorkers’ health. Until cannabidiol (CBD) is deemed safe as a food additive, the Department is ordering restaurants not to offer products containing CBD” a spokeswoman for the health department said, reports Wall Street Journal;
5/02/2019 Adding Cannabis To The Mix: Risks And Benefits For Seniors - Because of federal restrictions associated with its Schedule 1 status, millions of Americans are using cannabis with no or limited guidance on how it may interact with their other medicines. Baby Boomers and elder adults, who often suffer from multiple chronic health conditions and are taking numerous medications, are potentially at a much greater risk from drug interactions when adding cannabis. But how much concern over cannabis use is actually warranted? A recent study in the New England Journal of Medicine sets a cautionary tone: “Older adults with coexisting chronic medical conditions who use marijuana may be at risk for cognitive changes, falls, and interactions with prescription medications” Dr. Andrew Peterson, Executive Director of the Substance Use Disorders Institute and a professor of clinical pharmacy and health policy at Philadelphia’s University of the Sciences, emphasizes that older adults’ physiologic responses to drugs make them more vulnerable than the average population, reports Forbes;
5/02/2019 Wall Street banks face hurdles as they rush to cover the suddenly booming marijuana industry - Goldman Sachs star beverage and tobacco analyst Judy Hong was hoping to do some early research into the multibillion-dollar cannabis industry — that is, until she was stopped by the investment bank’s firewall blocking certain content. Among the companies the 20-year Goldman veteran tried to review was KushCo Holdings, a California-based business that sells packaging, containers and other supportive products to the world’s largest cannabis producers. And though no part of KushCo’s business actually touches a marijuana or hemp plant, Hong found herself nonetheless barred from the company’s website, said a KushCo executive familiar with the matter. Bank of America Merrill Lynch’s consumer analyst is also researching KushCo and the space, the person added. Both Goldman Sachs and Bank of America Merrill Lynch declined to comment about their plans for future marijuana-related research coverage. The KushCo executive said it’s fielded calls and met with representatives of both banks, reports CNBC;
4/02/2019 Cannabis jobs pay 11% more than the US median salary - As more states legalize cannabis usage, the industry that provides the drug has gotten a burst of confidence in its long-term prospects and is rapidly expanding. Job openings rose 76 percent from December 2017 to December 2018, with 1,512 open roles posted in that final month of 2018 alone, according to Glassdoor. Back in 2017, that number was only 858. The industry’s acceleration doesn’t appear to be slowing down anytime soon either, as this latest upsurge only continues a trend Glassdoor has been observing over the past few years, thanks to loosening restrictions on the drug. “As the cannabis industry becomes more legitimate, more and more professional roles will be in demand to help businesses comply with tax laws and regulations and scale into larger markets,” Daniel Zhao, an economist and data scientist with Glassdoor, wrote, reports CNBC. "
Deshalb behalte ich ja auch River Wild Expl./Centr Brands im Auge.Könnte genau wieder so ne Aktion mit Drescher werden wie eben schon bei RQB.

Die Zeit von Mai-November 2017 kannste knicken.Da haben einzig und allein die Insider Kasse gemacht.Schau Dir nur mal an zu welchen Preisen ( 0,05 CAD) da in der Umfirmierung PP' gemacht wurden.Es gab noch kein richtiges Geschäftsmodell,alles am Anfang.Kaum einer kannte diese Aktie.

Antwort auf Beitrag Nr.: 59.836.330 von boersensoldat am 10.02.19 14:50:56vielleicht wird das ja hier auch eine zweite Great Bear Resources.

Naja, ich finde Es sehr oft "witzig" Wie AKtien bemessen werden.
Von Low/High war RQB SCHON >20.000%.

eine turbolente Woche liegt hinter uns mit fallenden Kursen.Zumindest das Volumen war nicht so hoch,das ist schon mal gut.
Hoffen wir mal das dieses Theater, mit Bonify/HC, nicht RQB in Bezug auf die baldige Lizenzerteilung auf die Füsse fällt.Wie schon mal mal weiter oben erwähnt werden wir wohl den Zeithorizont ein ganzes Stück erweitern müssen.
Aber vielleicht wird das ja hier auch eine zweite Great Bear Resources.Die lag bei mir auch ewig im Depot aber immer daran geglaubt und dann diese Kursentwicklung.

Von daher...... facit omnia voluntas ......


Beitrag zu dieser Diskussion schreiben